HCA Healthcare, Inc.
NYSE•HCA
CEO: Mr. Samuel N. Hazen
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date: 2011-03-10
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Contact Information
Market Cap
$121.90B
P/E (TTM)
18.5
16.1
Dividend Yield
0.5%
52W High
$552.90
52W Low
$310.18
52W Range
Rank22Top 8.4%
5.9
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.9 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025
Financial Dashboard
Q4 2025 Data
Revenue
$19.51B+6.72%
4-Quarter Trend
EPS
$8.14+42.81%
4-Quarter Trend
FCF
$870.00M-31.71%
4-Quarter Trend
2025 Annual Earnings Highlights
Key Highlights
Net Income Rises Sharply Net income attributable $6.784 B USD, reflecting 17.8% increase over 2024 results; diluted EPS $28.33 USD.
Revenue Growth Solidifies Revenues reached $75.600 B USD in 2025, marking 7.1% consolidated growth; equivalent admissions increased 2.9%.
Strong Operating Cash Flow Cash from operations totaled $12.636 B USD, increasing $2.122 B from prior year, supporting capital needs.
Facility Footprint Expansion Operated 190 hospitals with 50,436 licensed beds as of year-end 2025; added 121 ASCs and 31 endoscopy centers.
Risk Factors
High Indebtedness Exposure Total indebtedness stands at $46.492 B USD; debt covenants limit operational flexibility and refinancing terms uncertain.
Labor Costs and Staffing Competition for experienced nurses and physicians may increase labor costs above historical rates, impacting margins.
Cybersecurity Incident Threat Cybersecurity incidents risk compromising critical data systems, leading to potential patient harm, litigation, and reputation damage.
Government Reimbursement Pressure Ongoing uncertainty in Medicare/Medicaid policy, including FBA changes, may negatively impact reimbursement levels and revenues.
Outlook
Advance Digital Capabilities Strategy emphasizes investing in digital, data, and AI solutions to drive operational efficiency and improve clinical decision-making at scale.
Pursue Disciplined Growth Focus on selectively acquiring new hospitals and outpatient facilities to complement in-market growth agenda and achieve cost savings.
Manage Policy Uncertainty Expecting revenue decline from SDP arrangements in 2026 due to FBA changes, partially offset by ongoing resiliency efforts.
Enhance Workforce Development Dedicated to recruiting and retaining talent, expanding nursing education via Galen College and upskilling programs.
Peer Comparison
Revenue (TTM)
$402.07B
$397.96B
$274.95B
Gross Margin (Latest Quarter)
85.6%
70.3%
70.0%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| PFE | $152.45B | 19.6 | 8.7% | 32.4% |
| SYK | $140.03B | 43.1 | 15.0% | 31.1% |
| BMY | $123.47B | 17.5 | 39.3% | 52.4% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
2.1%
Moderate Growth
4Q Net Income CAGR
5.3%
Profitability Improving
Cash Flow Stability
100%
Strong Cash Flow
Deep Research
Next earnings:Apr 23, 2026
EPS:-
|Revenue:-
Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement | LTM |
|---|
No Data